Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2

Currently, there are over 230 different COVID-19 vaccines under development around the world. At least three decades of scientific development in RNA biology, immunology, structural biology, genetic engineering, chemical modification, and nanoparticle technologies allowed the accelerated development...

Descripción completa

Detalles Bibliográficos
Autores principales: Granados-Riveron, Javier T., Aquino-Jarquin, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299225/
https://www.ncbi.nlm.nih.gov/pubmed/34343897
http://dx.doi.org/10.1016/j.biopha.2021.111953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299225/
https://www.ncbi.nlm.nih.gov/pubmed/34343897
http://dx.doi.org/10.1016/j.biopha.2021.111953

Ejemplares similares